Article Information
History
- July 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Helen Ward, PhD1,2,4,5,†,
- Matt Whitaker, MSc1,
- Sonja N Tang, MSc1,
- Christina Atchison, PhD1,
- Ara Darzi, PhD4,6,
- Christl A Donnelly, ScD1,2,7,
- Peter J. Diggle, PhD8,
- Deborah Ashby, PhD1,
- Steven Riley, PhD1,2,
- Wendy S Barclay, PhD3,
- Paul Elliott, PhD*,1,4,5,9,10,11,† and
- Graham Cooke, PhD*,3,4,5
- 1School of Public Health, Imperial College London, UK
- 2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
- 3Department of Infectious Disease, Imperial College London, UK
- 4Imperial College Healthcare NHS Trust, UK
- 5National Institute for Health Research Imperial Biomedical Research Centre, UK
- 6Institute of Global Health Innovation at Imperial College London, UK
- 7Department of Statistics, University of Oxford, UK
- 8CHICAS, Lancaster Medical School, Lancaster University, UK and Health Data Research, UK
- 9MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
- 10Health Data Research (HDR) UK London at Imperial College London, UK
- 11UK Dementia Research Institute at Imperial College London, UK
- ↵†Corresponding author: Prof Helen Ward, h.ward{at}imperial.ac.uk, +44 20 75 94 33 03 or Prof Paul Elliott, p.elliott{at}imperial.ac.uk
↵* Contributed equally
Posted July 18, 2021.
Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study
